Literature DB >> 12821499

Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline.

Jutta Wagner1, Miriam Jabbusch, Martin Eisenblätter, Helmut Hahn, Constanze Wendt, Ralf Ignatius.   

Abstract

To elucidate Campylobacter jejuni resistance to antibiotics in Germany, MICs of ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline were determined (using agar dilution) for 144 clinical isolates. The data indicate a considerable ciprofloxacin resistance (45.1%) without a clonal relationship of the strains and a greater in vitro activity of moxifloxacin, erythromycin, and clindamycin.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12821499      PMCID： PMC161846          DOI： 10.1128/AAC.47.7.2358-2361.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  27 in total

1.  The stability of grlA, grlB, gyrA, gyrB and norA mutations and MIC values of five fluoroquinolones in three different clonal populations of methicillin-resistant Staphylococcus aureus.

Authors:  Franz-Josef Schmitz; Karl Köhrer; Sybille Scheuring; Jan Verhoef; Ad Fluit; Hans-Peter Heinz; Mark E. Jones
Journal:  Clin Microbiol Infect       Date:  1999-05       Impact factor: 8.067

2.  In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas.

Authors:  C M Bébéar; H Renaudin; A Boudjadja; C Bébéar
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

3.  Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona.

Authors:  G Prats; B Mirelis; T Llovet; C Muñoz; E Miró; F Navarro
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

Authors:  H P Endtz; G J Ruijs; B van Klingeren; W H Jansen; T van der Reyden; R P Mouton
Journal:  J Antimicrob Chemother       Date:  1991-02       Impact factor: 5.790

5.  Prevalence of Campylobacter spp. in poultry and poultry meat in Germany.

Authors:  V Atanassova; C Ring
Journal:  Int J Food Microbiol       Date:  1999-10-15       Impact factor: 5.277

6.  In vitro activity of BAY 12-8039, a new fluoroquinolone.

Authors:  J M Woodcock; J M Andrews; F J Boswell; N P Brenwald; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis.

Authors:  J C Rodríguez; M Ruiz; A Climent; G Royo
Journal:  Int J Antimicrob Agents       Date:  2001-03       Impact factor: 5.283

8.  Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC.

Authors:  A Gibreel; E Sjögren; B Kaijser; B Wretlind; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

9.  Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.

Authors:  Y Wang; W M Huang; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

10.  Epidemiological typing of Campylobacter isolates from meat processing plants by pulsed-field gel electrophoresis, fatty acid profile typing, serotyping, and biotyping.

Authors:  M Steele; B McNab; L Fruhner; S DeGrandis; D Woodward; J A Odumeru
Journal:  Appl Environ Microbiol       Date:  1998-07       Impact factor: 4.792
View more
  5 in total

1.  Genetic relatedness and quinolone resistance of Campylobacter jejuni strains isolated in 2002 in Hong Kong.

Authors:  Yiu-Wai Chu; Man-Yu Chu; Kit-Yee Luey; Yin-Wa Ngan; Ka-Lok Tsang; Kai-Man Kam
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland.

Authors:  Sebastian Wardak; Jolanta Szych; Aleksandra Anna Zasada; Rafal Gierczynski
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

3.  Antimicrobial susceptibilities of Campylobacter jejuni isolates from hospitalized children in Athens, Greece, collected during 2004-2005.

Authors:  Eleni Papavasileiou; Aliki Voyatzi; Konstantina Papavasileiou; Antonia Makri; Ioanna Andrianopoulou; Stylianos Chatzipanagiotou
Journal:  Eur J Epidemiol       Date:  2006-12-21       Impact factor: 8.082

Review 4.  A Historical Review on Antibiotic Resistance of Foodborne Campylobacter.

Authors:  Yichao Yang; Kristina M Feye; Zhaohao Shi; Hilary O Pavlidis; Michael Kogut; Amanda J Ashworth; Steven C Ricke
Journal:  Front Microbiol       Date:  2019-07-26       Impact factor: 5.640

5.  Prevalence and antimicrobial susceptibility of Arcobacter species in human stool samples derived from out- and inpatients: the prospective German Arcobacter prevalence study Arcopath.

Authors:  Greta Gölz; Markus M Heimesaat; Vanessa Brückner; Ulrike Fiebiger; Ralf Ignatius; Johannes Friesen; Martin Eisenblätter; Marlies Höck; Thomas Alter; Stefan Bereswill
Journal:  Gut Pathog       Date:  2020-04-15       Impact factor: 4.181
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.